In our study, clusterin showed no significant association with ESCC prognosis in univariate analysis (P = 0.392), but in multivariate and survival curve analysis, sCLU overexpression (>500 μg/mL) was related to better prognosis (P = 0.030). Here, CLU is linked to esophageal squamous cell carcinoma.